annual cash & cash equivalents:
$127.57M-$5.95M(-4.46%)Summary
- As of today (September 17, 2025), SANA annual cash & cash equivalents is $127.57 million, with the most recent change of -$5.95 million (-4.46%) on December 31, 2024.
- During the last 3 years, SANA annual cash & cash equivalents has fallen by -$125.46 million (-49.58%).
- SANA annual cash & cash equivalents is now -49.58% below its all-time high of $253.03 million, reached on December 31, 2021.
Performance
SANA Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$76.87M-$32.03M(-29.41%)Summary
- As of today (September 17, 2025), SANA quarterly cash & cash equivalents is $76.87 million, with the most recent change of -$32.03 million (-29.41%) on June 30, 2025.
- Over the past year, SANA quarterly cash & cash equivalents has dropped by -$178.61 million (-69.91%).
- SANA quarterly cash & cash equivalents is now -91.99% below its all-time high of $960.24 million, reached on March 31, 2021.
Performance
SANA quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
SANA Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -4.5% | -69.9% |
| 3 y3 years | -49.6% | -84.1% |
| 5 y5 years | +59.4% | -79.7% |
SANA Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -49.6% | at low | -84.4% | at low |
| 5 y | 5-year | -49.6% | +59.4% | -92.0% | at low |
| alltime | all time | -49.6% | +316.5% | -92.0% | at low |
SANA Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $76.87M(-29.4%) |
| Mar 2025 | - | $108.90M(-30.3%) |
| Dec 2024 | $127.57M(-4.5%) | $156.33M(-22.9%) |
| Sep 2024 | - | $202.84M(-20.6%) |
| Jun 2024 | - | $255.47M(-18.9%) |
| Mar 2024 | - | $314.91M(+50.7%) |
| Dec 2023 | $133.52M(-24.5%) | $209.03M(-23.3%) |
| Sep 2023 | - | $272.40M(-18.0%) |
| Jun 2023 | - | $332.01M(-6.6%) |
| Mar 2023 | - | $355.41M(-17.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $176.76M(-30.1%) | $430.06M(-12.6%) |
| Sep 2022 | - | $491.85M(+1.5%) |
| Jun 2022 | - | $484.80M(-5.4%) |
| Mar 2022 | - | $512.38M(-7.0%) |
| Dec 2021 | $253.03M(+102.7%) | $551.00M(-8.7%) |
| Sep 2021 | - | $603.71M(-29.2%) |
| Jun 2021 | - | $852.84M(-11.2%) |
| Mar 2021 | - | $960.24M(+153.9%) |
| Dec 2020 | $124.81M(+55.9%) | $378.26M(+172.2%) |
| Dec 2019 | $80.03M(+161.3%) | $138.98M |
| Dec 2018 | $30.63M | - |
FAQ
- What is Sana Biotechnology, Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Sana Biotechnology, Inc.?
- What is Sana Biotechnology, Inc. annual cash & cash equivalents year-on-year change?
- What is Sana Biotechnology, Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Sana Biotechnology, Inc.?
- What is Sana Biotechnology, Inc. quarterly cash & cash equivalents year-on-year change?
What is Sana Biotechnology, Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of SANA is $127.57M
What is the all time high annual cash & cash equivalents for Sana Biotechnology, Inc.?
Sana Biotechnology, Inc. all-time high annual cash & cash equivalents is $253.03M
What is Sana Biotechnology, Inc. annual cash & cash equivalents year-on-year change?
Over the past year, SANA annual cash & cash equivalents has changed by -$5.95M (-4.46%)
What is Sana Biotechnology, Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of SANA is $76.87M
What is the all time high quarterly cash & cash equivalents for Sana Biotechnology, Inc.?
Sana Biotechnology, Inc. all-time high quarterly cash & cash equivalents is $960.24M
What is Sana Biotechnology, Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, SANA quarterly cash & cash equivalents has changed by -$178.61M (-69.91%)